ZEPHYR AI
Live / Applied — Fourth extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 28 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97524671
- Mark type
- Stylized text
- Filed
- 28 Jul 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Karen Won
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence for machine learning for scientific and medical research and development; downloadable computer software, software platforms, downloadable mobile applications, and downloadable software programs using artificial intelligence and machine learning technologies for scientific and medical research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals
- Class 042 — Scientific and technological services: Scientific research consulting services in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific and medical research analysis of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; genetic and tumor mapping for scientific and medical research purposes; providing medical and scientific research information in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; drug discovery services; scientific services, namely, analyzing medical, genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific, medical and clinical research and scientific, medical and clinical research consulting services in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals by using machine learning, artificial intelligence technology, and biotechnology; medical and scientific research and consulting, namely, designing and organizing clinical trials for others; research and development services in the creation of databases and collections of information and data on biologicals for research purposes; providing genetic reference databases being collections of gene sequences for research purposes; disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; genetic research for identifying biomarker rankings for medical purposes; research and development of pharmaceutical preparations and medicines; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of medical treatment and diagnosis, including for cancer and diabetes; providing temporary use of online non-downloadable software, cloud-based software, platform as a service (PAAS) featuring computer software platforms, and a website featuring technology, all for enabling users to use artificial intelligence for machine learning in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; software installation and maintenance; DNA analysis services for scientific and medical research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning
- Class 044 — Medical, beauty and agricultural services: Healthcare;medical services;consulting services in the field of healthcare, medicine, and medical use of pharmaceuticals; healthcare, medical, and pharmaceutical medical use information services; DNA screening for medical purposes; clinical medical consultation services; healthcare, medical, and pharmaceutical services, namely, providing databases in the fields of medical, scientific, genetic, oncological, and biological information for inputting, collecting, analyzing, and managing data for treatment and diagnostic purposes; healthcare and medical services, namely, analyzing medical, genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing medical consulting services in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals by using machine learning, artificial intelligence technology, and biotechnology
Owner
- Zephyr AI, Inc, Dallas, TX, US
- Zephyr AI, Inc, Dallas, TX, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 4 GRANTED
- 18 Nov 2025 — SOU EXTENSION 4 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2025 — SOU EXTENSION 3 GRANTED
- 21 Mar 2025 — SOU EXTENSION 3 FILED
- 21 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 2 GRANTED